Detected ·
Hexagon Bio
$62MSeries C
Hexagon Bio raised $62M in Series C funding to advance its lead cancer drug candidate HEX-360, discovered via its microbial genomics platform.
- Website
- www.hexagonbio.com
- linkedin.com/company/18173401
- Amount
- $62 000 000 USD
- Stage
- Series C
- Event
- Funding round
- Detected
- 2026-11-02 00:03:30 UTC
- Signal ID
- 3ad10bbd-21a1-480d-997a-46645c36ad67
As the API returns it
{
"id": "3ad10bbd-21a1-480d-997a-46645c36ad67",
"created_at": "2026-11-02T00:03:30.143262Z",
"company_name": "Hexagon Bio",
"company_website_url": "www.hexagonbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/18173401",
"event_type": "funding",
"funding_amount": 62000000,
"funding_currency": "USD",
"funding_stage": "series_c",
"message": "*Hexagon Bio raised $62M in Series C funding to advance its lead cancer drug candidate HEX-360, discovered via its microbial genomics platform.*"
}